CBRF-BRIF Stage 2  

On this page:

Overview

The Canada Biomedical Research Fund and Biosciences Research Infrastructure Fund (CBRF-BRIF) competition is a key component of the Government of Canada’s Biomanufacturing and Life Sciences Strategy. The competition aims to build a strong, competitive biomanufacturing and life sciences sector that will ensure Canada is prepared for future pandemics and health threats by increasing domestic capacity to produce life-saving vaccines and therapeutics. 

As part of Stage 2 of the integrated CBRF-BRIF competition, CIEBH coordinated research and infrastructure project submissions toward a share of $575M in federal funding. 

We are pleased to have submitted a comprehensive portfolio of proposals that aims to significantly bolster Canada’s bioinnovation capabilities. The proposals were developed collaboratively from CIEBH’s partners across the private, public, not-for-profit and academic sectors.  

The results of the competition are expected to be announced in early 2024. 

For more information, visit the CBRF-BRIF Stage 2 overview page.

Key dates

  • September 7, 2023: Proposal submission deadline
  • March 2024: Results expected to be announced

Resources

Proposal criteria

Proposals were selected based on their alignment with CIEBH’s priorities through a framework of priority pillars and cross cutting themes (Figure 1). These thematic platforms include a focused program of talent development spanning the training continuum, as well as an innovative best-in-class regulatory program. Our suite of projects addresses critical infrastructure and capacity gaps, facilitating rapid translation of therapeutics through flexible early-stage GMP biomanufacturing and clinical trials infrastructure. 

A fundamental principle of CIEBH’s strategy is that equity, diversity, and inclusion (EDI) drive excellence in creation and discovery. There are persistent systemic barriers that require proactive action to ensure 1) a diverse and inclusive workforce and 2) that curiosity-driven science and clinical trials include varied perspectives and populations—i.e., racialized individuals, Indigenous Peoples, persons with disabilities, women and gender-diverse people as well as rural and remote populations—so that outcomes benefit everyone.

CIEBH will draw on the expertise of institutional EDI resources at all participating academic partner institutions and has established an EDI research strategy. As well, by incorporating the social sciences and humanities into our program, we will position the workforce of the future to have a more holistic, society-centered perspective that is critical to developing equitable solutions to health threats.  

Figure 1: CIEBH’s priority research pillars and themes

CBRF-BRIF award budget

Table 1: CBRF-BRIF Stage 1 & 2 budget breakdown

Last updated: Dec 8, 2023